Chinese Peptide Co, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is CETRORELIX ACETATE, with a corresponding US DMF Number 34884.
Remarkably, this DMF maintains an Active status since its submission on June 08, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 01, 2020, and payment made on July 20, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II